PE/Cy7® Anti-PD1 antibody [EH12.2H7]
Be the first to review this product! Submit a review
|
(1 Publication)
Mouse Monoclonal PD1 antibody - conjugated to PE/Cy7®. Suitable for Flow Cyt and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human PDCD1.
View Alternative Names
CD279, PD1, PDCD1, Programmed cell death protein 1, Protein PD-1, hPD-1
- Flow Cyt
Supplier Data
Flow Cytometry - PE/Cy7® Anti-PD1 antibody [EH12.2H7] (AB270681)
Flow cytometry analysis of human PHA stimulated peripheral blood mononuclear labeling PD1 (CD279) using ab270681. Surface staining.
- Flow Cyt
Supplier Data
Flow Cytometry - PE/Cy7® Anti-PD1 antibody [EH12.2H7] (AB270681)
Flow cytometry analysis of human PHA stimulated peripheral blood mononuclear labeling PD1 (CD279) using ab270681 (Red). Surface staining.
Control : CD279 negative blood debris (Black).
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PD1 serves as an inhibitory receptor acting as a checkpoint in the immune system. It becomes part of an immune-suppressive complex when it binds with its ligands PD-L1 or PD-L2 which are expressed on various cell types including some tumor cells. This interaction suppresses the proliferation of T cells and cytokine production contributing to immune homeostasis. By controlling T cell activity PD1 limits autoimmunity but can also reduce the immune system's capability to attack cancer cells.
Pathways
PD1 functions in the immune checkpoint pathway a critical regulatory circuit in immune regulation. The engagement of PD1 with its ligands initiates a cascade that inhibits the function and proliferation of T cells through downstream SHP-2 phosphatase activity. This pathway frequently involves other regulatory proteins like CTLA-4 and is an important mechanism by which the body modulates immune responses. Related pathways often intersect with those involving T cell receptor signaling and contribute to the overall modulation of immune activity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in oncology 12:904969 PubMed35978822
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com